STIMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Neuronetics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$1.91+0.02 (+1.33%)
Close on Oct 19, 2026
- Market cap
- $139.68M
- P/E (TTM)
- –
- Dividend yield
- –
Neuronetics, Inc. revenue by segment
By business segment
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Greenbrook | $26.89M | – | – | – | $23.02M | – | – | – | – | – | 64.7% | +16.8% |
| NeuroStar | $14.68M | – | – | – | $15.08M | – | – | – | – | – | 35.3% | -2.7% |
| Med Device | – | $12.93M | – | $37.30M | $38.11M | $13.32M | $18.05M | $18.53M | $16.45M | $17.42M | – | – |
| Clinic Service | – | $21.53M | – | – | – | $18.66M | – | – | – | – | – | – |
| Operating income | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NeuroStar | $3.13M | – | – | – | $146.00K | – | – | – | – | – | +2043.8% |
| Greenbrook | $2.19M | – | – | – | -$405.00K | – | – | – | – | – | -641.0% |
| Med Device | – | $1.34M | $29.64M | -$7.32M | -$8.06M | -$136.00K | $18.49M | -$7.73M | -$8.51M | -$6.86M | – |
| Clinic Service | – | -$1.86M | – | – | – | -$2.41M | – | – | – | – | – |
By product or service
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Greenbrook | $26.89M | $21.53M | – | – | $23.02M | $18.66M | – | – | – | – | 64.7% | +16.8% |
| NeuroStar | $14.68M | $12.93M | – | – | $15.08M | $13.32M | – | – | – | – | 35.3% | -2.7% |
By region
From the segment and revenue-disaggregation notes of Neuronetics's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.